Silvia Sookoian
@SSookoian
Followers
251
Following
1K
Media
74
Statuses
484
Physician Scientist, passion for science, a life devoted to patients care.
Buenos Aires City Region, Argentina
Joined May 2017
RT @CMH_journal: Exciting news! "Clinical and Molecular Hepatology" has achieved a 2024 Impact Factor of 16.9, ranking 6th out of 143 in Ga….
0
4
0
RT @maimonidesedu: Avances en la enfermedad conocida como hígado graso. Científicos del @CONICETDialoga y de UMAI identifican una proteína….
0
2
0
RT @maimonidesedu: Hoy, en la Academia Nacional de Medicina le entregamos el Doctorado Honoris Causa a Luis Acero, prestigioso médico españ….
0
2
0
RT @VCU_Liver: With @ArunJSanyalVCU, @SSookoian, @cjpirola. A call to recognize MASLD/MASH as a NCD. #livertwitter New in @NatRevGastroHep.
0
2
0
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
onlinelibrary.wiley.com
Proteomics and the analysis of protein–protein interactions and networks may identify the effectors of the disease and the target of pharmacological interventions. This review presents a synthesis...
1
4
8
Thank you for sharing this!.
#CGH4ALL📣💥. A complete and thorough review of genetics🧬& MASLD @AGA_CGH🔥!. 🔗 #MASLD #livertwitter #GITwitter.Reported by @ifrahfatima. @SSookoian.@lucavalenti75.@scottisaacsmd.@ArunJSanyalVCU.@BrettEFortuneMD.@Dr_Vijay_Shah.@DougSimonetto
0
2
10
RT @lucavalenti75: Remember to screen first degree relatives for case finding of advanced #masld @stefano_romeo76 @SSookoian @NASH_and_coff….
0
6
0
👏🏻Congrats Federica, @stefano_romeo76 @lucavalenti75 and teamwork. Excellent work!!!.
Honored to share our recently published paper in @NatureMedicine🔥shedding light on MASLD heterogeneity #LiverTwitter @AASLDtweets @EASLnews. 🗝️2 types of at-risk MASLD: same liver histology, distinct clinical trajectories and biological profiles. 👉
0
2
9
Nice review! Congratulations @lucavalenti75 and team.
ONLINE NOW: Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
0
0
7
Thank you @NODGastro and Kerry, great EICs for this opportunity to share with you and some other talented people this awesome task.
0
1
5
RT @EricTopol: Never underestimate the gut microbiome's potential impact. New @NatureMedicine .A younger metabolic age gut microbiome count….
0
213
0
RT @EricTopol: The first drug approved for MASH, along with the global toll of this disease, summarized (e.g. ~30% of world population w/ M….
0
127
0
Especialistas del CONICET analizan en <i>Cell</i> las perspectivas del primer fármaco para tratar la enfermedad del hígado graso en su estadio más avanzado Muchas gracias @CONICETDigital por compartir. Ciencia 🇦🇷 ! Agradecidos a @CellCellPress.
conicet.gov.ar
.
1
0
0
Thank you patients and advocacy groups, and nurses and doctors who made this possible. @fattyliverday @FattyLiverA.
1
0
0
@Mayo_liverdoc @DrLoomba @NoureddinMD @marurinella @QAnstee @VCU_Liver @AlkhouriNaim @mcharltonmd @FrancqueSven and many others, including Dr. Stephen Harrison.
1
0
1
Resmetirom for treatment of MASH Honored by the invitation to summarize with @cjpirola this achievement from the biological perspective and implications. Thank you @CellCellPress and of course the brilliant team of the Resmetirom trial!.
1
1
3
RT @Gut_BMJ: #GUTImage from the #RecentAdvancesInClinicalPractice paper by @JonelTrebicka et al entitled "Recent advances in the prevention….
0
10
0